SLFN11 and breast carcinoma: revealed that elevated levels of SLFN11 expression in breast cancer is associated with increased invasiveness and immunoactivated tumors, in contrast, lack of significant SLFN11 expression is associated with tumors that are less aggressive and exhibit immunosuppressive characteristics (28).